Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Legislative Outlook: Animal Drug User Fee Could Carry Human Drug Proposals

Executive Summary

ADUFA reauthorization may become the vehicle to move track and trace and compounding legislation. Reimbursement changes to mitigate shortages appear less likely.


Related Content

Fiscal Cliff Legislation Adjusts ESRD Payment Bundle To Help Offset Doc Fix
FDA Shortage Notification Mandate May Not Extend To Biologics
FDASIA Study Mandates Focus On Performance, But Could Slow Reviews
With GAIN In Place, Antibiotic Improvements Depend On FDA Implementation
Bioterror “Strategic Investor” Initiative Must Be Resolved As House, Senate Pass Dueling Bills
Supply Chain Safety’s Dual Visions: Pedigree Or Just Serialization





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts